Navigation Links
SC&H Capital Advises iVantage in Acquisition of Professional Data Services
Date:10/31/2013

Baltimore, MD (PRWEB) October 31, 2013

SC&H Capital, an investment banking and advisory firm focused on middle market and growth companies, served as the exclusive financial advisor for the acquisition of Professional Data Services (PDS) by iVantage Health Analytics, Inc.

The addition of PDS represents the continued expansion of the iVantage Health Analytics solution suite into the marketplace. PDS offers managed care analytics, internal/external payment benchmarking solutions to support payor negotiations, and strategic planning/execution services for hospitals.

Originally developed for hospitals at the Hospital Association of Southern California (HASC), PDS provides a Software-as-a-Service (SaaS) based analytic tool developed to help with hospital revenue optimization and benchmarking by using proprietary paid claims data. Hospital associations around the country are adopting this tool to support their association members’ needs for bundled payment contracting.

“We were pleased to be able to serve as the trusted advisor to iVantage throughout the entire lifecycle of this deal,” said Kevin O’Sullivan, Senior Vice President at SC&H Capital. “This is a significant deal because it will allow iVantage to help its hospital clients make better business decisions in a health care climate that is becoming increasingly regulated.”

Financial terms of the acquisition were not disclosed.

About SC&H Capital
SC&H Capital, an affiliate of SC&H Group, LLC, is an investment banking and advisory firm focused on middle market and growth companies. SC&H Capital supports their investment banking activity with a full suite of strategic and financial resources to assist companies in the development and execution of strategic plans and initiatives. In conjunction with SC&H Group, LLC, SC&H Capital tailors their advisory services to ensure that their clients receive pertinent and valuable advice in every stage of the business life cycle – not just at the time of sale.

About iVantage Health Analytics
iVantage is a leading provider of health care informatics and business analytics solutions that transform complex data into actionable business intelligence. This platform is used by hospital management teams to drive empirical and evidence based decision making. These tools are positioned at the center of a large market opportunity due to increased demand for meaningful data, driven by new compliance based requirements and operational challenges of the Patient Protection and Affordable Care Act (“PPACA”). iVantage has been growing at approximately 50% per year.

Securities offered through Stout Causey Capital Corporation, member FINRA/SIPC.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11277608.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Vopne Capital Launches $20 Million Buyout Fund
2. Real Food Works Receives Investment From First Round Capital and StartUp PHL’s Innovative City-Backed Fund
3. Grand Opening of Healthy Living Center Marks Advancement in Wellness for Capital Region
4. Capital Institute for Neurosciences Launches Alzheimer's Program; Specialized Center Provides Latest Technology, Care and Family Support
5. Financial Advisor Plano, TX and Financial Planner Plano, TX "Best of the Best" Awarded to VAL-Trust Capital Partners, LLC for Excellence by Follow Media Consulting, Inc.
6. Thailand’s Capital to Host the 14th World Gourmet Festival
7. NuvoH2O Engages Hickey Freihofner Capital for Strategic Financial Advisory Services
8. CDPHP® Workforce Team Challenge Gives $12,000 to Capital District Community Gardens
9. Human Capital Resource, LLC, Adds Contract Staffing to Its Recruiting Services
10. US Freedom Capital Announces US Government Approval
11. NVCA Study Explores The Importance of Brand Management in The Venture Capital Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Dr. Angela Cotey, a noted general ... accepting new pediatric patients, with or without a referral. Dr. Cotey knows that ... orthodontic outcome and experience. When patients receive early treatment, they may achieve straight teeth ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... buildings (MOBs) and other outpatient facilities, and who are the most active developers? ... those questions, Revista and Healthcare Real Estate Insights (HREI) found that outpatient medical ...
(Date:3/29/2017)... ... , ... Curio Wellness , a premium medical cannabis brand and trusted ... management team with prominent executives from both inside and outside the cannabis industry. ... Ted Dumbauld , who has more than twenty years of business leadership and investment ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an important webinar ... at 1:00 PM ET. A recording of the webinar will also be made available ... Home health and hospice companies are still popular targets for healthcare investors. This highly ...
(Date:3/29/2017)... ... 2017 , ... Immunotherapy has emerged as one of the most promising options ... be the next revolution in our fight against this complex disease. One of the ... checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Calif. , March 29, 2017  Experts ... recognized remote monitoring devices like  Soberlink Systems  as ... The consensus paper, published in early 2017, concluded ... and valuable in managing patient recovery." ... the Journal of Addiction Medicine, detail a range ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, ... for GSP 301, an investigational fixed-dose combination of ... mcg) administered twice-daily as a nasal spray being ... These results are from a recently completed Phase ... GSP 301 combination therapy versus mometasone, olopatadine or ...
(Date:3/29/2017)... , Mar. 29, 2017 Research and ... Market 2017-2021" report to their offering. ... The global lifestyle drugs market to ... The report, Global Lifestyle Drugs Market 2017-2021, has been ... experts. The report covers the market landscape and its growth prospects ...
Breaking Medicine Technology: